Lv01
0 积分 2022-11-24 加入
Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment
26分钟前
待确认
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
54分钟前
已完结
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
4小时前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1个月前
已完结
First-line inavolisib/placebo + palbociclib + fulvestrant (Inavo/Pbo+Palbo+Fulv) in patients (pts) with PIK3CA-mutated, hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer who relapsed during/within 12 months (mo) of adjuvant endocrine therapy completion: INAVO120 Phase III randomized trial additional analyses
1个月前
已完结
Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform
2个月前
已完结
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
2个月前
已完结
Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer
2个月前
已完结
Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)
2个月前
已完结
Novel immune check point inhibiting antibodies in cancer therapy—Opportunities and challenges
2个月前
已完结
皖公网安备34019202002308
